SCHEMBL8093762

SCHEMBL8093762

COC(=O)c1ccc(S)c(I)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.52
CA2 P00918 4/20 0.52
CA12 O43570 3/20 0.52
CA7 P43166 3/20 0.52
CA9 Q16790 3/20 0.52
CA14 Q9ULX7 3/20 0.52
XDH P47989 1/20 0.52
MAPT P10636 4/20 0.47
ALDH1A1 P00352 4/20 0.47
KDM4E B2RXH2 3/20 0.47
HPGD P15428 2/20 0.47
HSD17B10 Q99714 2/20 0.47
GLA P06280 1/20 0.47
GAA P10253 1/20 0.47
CASP1 P29466 1/20 0.47
CASP7 P55210 1/20 0.47
ATM Q13315 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
NOTUM Q6P988 1/20 0.46
MEN1 O00255 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31273942 1.00 CA1 (0.52) CA1CA2CA12CA7CA9
SCHEMBL550572 0.82 CA1 (0.57) CA1CA2CA12CA7CA9
SCHEMBL21383063 0.82 CA1 (0.57) CA1CA2CA12CA7CA9
SCHEMBL204112 0.81 CA1 (0.55) CA1CA2CA12CA7CA9
SCHEMBL30010685 0.79 TDP1 (0.53) CA1CA2CA12CA7CA9
SCHEMBL944597 0.79 CA1 (0.69) CA1CA2CA12CA7CA9
SCHEMBL1232173 0.79 TDP1 (0.53) CA1CA2CA12CA7CA9
SCHEMBL490266 0.79 KDM4E (0.62) CA1CA2CA12CA7CA9
SCHEMBL2451373 0.79 TDP1 (0.53) CA1CA2CA12CA7CA9
SCHEMBL6516101 0.79 CA1 (0.69) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024246764-A1 NOVEL BENZAMIDE DERIVATIVE COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 삼진제약주식회사 2024-12-05 WO disclosed
US-6030952-A AS HUMAN AND VETERINARY MEDICINE, PARTICULARLY IN THE TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR AND OPHTHALMOLOGIC CONDITIONS, AND IN COSMETIC COMPOSITIONS CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIOUES GALDERMA (FR) 2000-02-29 US disclosed